openPR Logo
Press release

Bronchitis Treatment Market Growth with Worldwide Industry Analysis to 2026

01-19-2017 08:55 AM CET | Health & Medicine

Press release from: Future Market Insights

Bronchitis Treatment Market Growth with Worldwide Industry

The chronic bronchitis is defined as the inflammation of the bronchi that lasts for more than 3 months for consecutive 2 years. The bronchi are the tubes which carry air in to the lungs. The major symptom of bronchitis is persistent cough associated with mucus expectoration, headache, nasal congestion, sore throat and fatigue. Risk factors for bronchitis include irritants, chemicals, air pollution and smoke. There are mainly two types of bronchitis–acute (short term) and chronic (long term). Acute bronchitis is mainly caused due to viral infection and last for around 10 to 15 days. The first line of treatment for acute bronchitis is symptomatic treatment, however, if the symptoms persists, antimicrobial therapy is advised. Mostly antibacterial such as clarithromycin or azithromycin are administered.

The treatment for chronic bronchitis includes bronchodilators and steroids. The bronchodilators such as albuterol (Ventolin, Proventil, Vospire, ProAir), metaporterenol (Alupent), formoterol and salmeterol, helps in relaxation of the smooth muscles of the bronchi which helps in expansion of the inner wall for better airway passage. Moreover, certain steroids are used such as prednisone, methylprednisolone that help in reducing the inflammation consequently helping in reduction of mucus secretion. Sometimes antibiotics are administered especially when there is an exacerbation of chronic bronchitis caused as a result of bacterial infection. Furthermore, PDE4 inhibitors are also being tested for their use in treatment of chronic bronchitis. For instance, Arcapta Neohaler received a FDA approval from Novartis

Bronchitis Treatment Market: Drivers and Restraints

Bronchitis treatment market is driven by sedentary lifestyle, addiction to cigarette smoke and chemical pollutants. Guidelines from the World Health Organization (WHO), stringent regulations to pollutant emission control, adherence to various international protocol such as Montreal Protocol and World Bank– Millennium Development Goal is expected to boost overall bronchitis treatment market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1277

Bronchitis Treatment Market: Segmentation

Bronchitis Treatment Market further segmented into following types

By Treatment:

Drugs

Oxygen therapy

By Class of Drugs:

Antibiotics

Bronchodilators

Mucolytics

Anti-inflammatory Drugs

By End User

Hospitals

Clinics

Drug stores

Bronchitis Treatment Market: Overview

Significant increase in respiratory disorders along with alarming rise in chemical pollutants is expected to drive the demand for effective bronchitis treatment. The market is expected to witness healthy growth during the forecast period.

Bronchitis Treatment Market: Region- wise Outlook

The global Bronchitis Treatment Market is expected to register significant CAGR during the forecast period. Depending on geographic regions, global Bronchitis Treatment Market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan, Japan and Middle East & Africa

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1277

North America dominates the global Bronchitis Treatment Market due to good awareness of healthcare in people and having good health care setup. Europe occupies second place in this market with its new regulations in the major economies. Asia Pacific is expected to witness fastest growth and is expected to gain significant market share over the forecast period.

Bronchitis Treatment Market: Key Players

Major players of this market include

Pfizer Inc.

GlaxoSmithKline Pharmaceuticals Limited

Sanofi Aventis

Boehringer Ingelheim

Dr. Reddy’s Laboratories Ltd

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Press: press@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchitis Treatment Market Growth with Worldwide Industry Analysis to 2026 here

News-ID: 416688 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Bronchitis

Bronchitis Market: Study Navigating the Future Growth Outlook
Global Bronchitis Market Report 2019 - Market Size, Share, Price, Trend and Forecast is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Bronchitis Market. Some of the key players profiled in the study are
Bronchitis Treatment Market: Rising Morbidity & Mortality Rate Leads to Dominanc …
Cough has been one of the most common illness-related reason for ambulatory visits in the United States. As the cough linked with bronchitis is so troublesome and slow to resolve, patients seek treatment. The use of biomarkers in identifying patients who might reap benefit from antibiotics is popular. However, the American Academy of Pediatrics cautions against the use of use of antibiotics for apparent viral respiratory illness, including pharyngitis, bronchitis
Global Bronchitis Drug Market Professional Survey Report 2018
This report studies Bronchitis Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/111008 This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Advanced Inhalation Therapies (AIT) Ltd,AstraZeneca Plc,DBV Technologies
Trends in the Bronchitis Treatment Market 2016-2026
The chronic bronchitis is defined as the inflammation of the bronchi that lasts for more than 3 months for consecutive 2 years. The bronchi are the tubes which carry air in to the lungs. The major symptom of bronchitis is persistent cough associated with mucus expectoration, headache, nasal congestion, sore throat and fatigue. Risk factors for bronchitis include irritants, chemicals, air pollution and smoke. There are mainly two types of
Chronic Bronchitis - Pipeline Research and Markets Insight, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Chronic Bronchitis - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Chronic Bronchitis. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265427 The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Chronic Bronchitis by development stage, therapy
Bronchitis Treatment Market Segments And Key Trends 2016-2026
The chronic bronchitis is defined as the inflammation of the bronchi that lasts for more than 3 months for consecutive 2 years. The bronchi are the tubes which carry air in to the lungs. The major symptom of bronchitis is persistent cough associated with mucus expectoration, headache, nasal congestion, sore throat and fatigue. Risk factors for bronchitis include irritants, chemicals, air pollution and smoke. There are mainly two types of